Near-patient HIV Viral Load Monitoring

Provides clinicians with a clearer view of disease progression, therapeutic compliance, and the emergence of drug resistance for HIV viral load testing. ExaVir Load is the only HIV viral load test able to detect all types and subtypes of HIV, including new strains, without any modification. That provides a more confident viral load assessment every run. Other HIV viral load tests are challenged in this regard because they are based on detection of viral RNA, which is prone to mutation. ExaVir Load’s RT platform measures the activity of the enzyme reverse transcriptase (RT), which is essential for HIV replication and is, therefore, maintained in all subtypes. Suitable for any lab conditions ExaVir Load is an ELISA-based test. That means it can be run in virtually any clinic. There is no need for specialized sample preparation and amplification rooms, or for costly capital investment. Running ExaVir Load requires only standard ELISA equipment and the inexpensive start-up equipment pictured below. That is why ExaVir Load has been used to decentralize HIV viral load testing in so many countries around the world. Making HIV viral load testing more accessible increases the quality of care provided and relieves pressure on central testing labs. The gold standard ExaVir Load offers gold-standard performance in the near-patient environment. Currently, RNA-based PCR tests are the gold standard used to reference HIV viral load tests. However, the cost and infrastructure requirements of these tests make them impractical for near-patient use. Several studies have compared ExaVir Load to the gold standard PCR test and each has found excellent correlation and comparable sensitivity and specificity.